| UniProt ID | PANX1_HUMAN | |
|---|---|---|
| UniProt AC | Q96RD7 | |
| Protein Name | Pannexin-1 | |
| Gene Name | PANX1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 426 | |
| Subcellular Localization |
Cell membrane Multi-pass membrane protein . Cell junction, gap junction . Endoplasmic reticulum membrane Multi-pass membrane protein . |
|
| Protein Description | Structural component of the gap junctions and the hemichannels. May play a role as a Ca(2+)-leak channel to regulate ER Ca(2+) homeostasis.. | |
| Protein Sequence | MAIAQLATEYVFSDFLLKEPTEPKFKGLRLELAVDKMVTCIAVGLPLLLISLAFAQEISIGTQISCFSPSSFSWRQAAFVDSYCWAAVQQKNSLQSESGNLPLWLHKFFPYILLLFAILLYLPPLFWRFAAAPHICSDLKFIMEELDKVYNRAIKAAKSARDLDMRDGACSVPGVTENLGQSLWEVSESHFKYPIVEQYLKTKKNSNNLIIKYISCRLLTLIIILLACIYLGYYFSLSSLSDEFVCSIKSGILRNDSTVPDQFQCKLIAVGIFQLLSVINLVVYVLLAPVVVYTLFVPFRQKTDVLKVYEILPTFDVLHFKSEGYNDLSLYNLFLEENISEVKSYKCLKVLENIKSSGQGIDPMLLLTNLGMIKMDVVDGKTPMSAEMREEQGNQTAELQGMNIDSETKANNGEKNARQRLLDSSC | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 10 | Phosphorylation | IAQLATEYVFSDFLL HHHHHHHHHHHHHHC | 11.48 | 25884760 | |
| 40 | S-nitrosocysteine | AVDKMVTCIAVGLPL HHHHHHHHHHHHHHH | 0.97 | - | |
| 40 | S-nitrosylation | AVDKMVTCIAVGLPL HHHHHHHHHHHHHHH | 0.97 | - | |
| 150 | Phosphorylation | MEELDKVYNRAIKAA HHHHHHHHHHHHHHH | 12.50 | - | |
| 171 | Phosphorylation | DMRDGACSVPGVTEN CCCCCCCCCCCCHHC | 30.71 | 30266825 | |
| 176 | Phosphorylation | ACSVPGVTENLGQSL CCCCCCCHHCHHHHH | 25.68 | 30266825 | |
| 182 | Phosphorylation | VTENLGQSLWEVSES CHHCHHHHHHHCCHH | 33.38 | 30266825 | |
| 187 | Phosphorylation | GQSLWEVSESHFKYP HHHHHHCCHHHCCCH | 23.13 | 30266825 | |
| 189 | Phosphorylation | SLWEVSESHFKYPIV HHHHCCHHHCCCHHH | 27.07 | 30108239 | |
| 199 | Phosphorylation | KYPIVEQYLKTKKNS CCHHHHHHHHCCCCC | 9.17 | 23403867 | |
| 201 | Ubiquitination | PIVEQYLKTKKNSNN HHHHHHHHCCCCCCC | 54.05 | - | |
| 203 | Acetylation | VEQYLKTKKNSNNLI HHHHHHCCCCCCCHH | 48.66 | 7226459 | |
| 204 | Acetylation | EQYLKTKKNSNNLII HHHHHCCCCCCCHHH | 71.49 | 7226469 | |
| 212 | Acetylation | NSNNLIIKYISCRLL CCCCHHHHHHHHHHH | 29.54 | 7226479 | |
| 255 | N-linked_Glycosylation | IKSGILRNDSTVPDQ ECCCCCCCCCCCCCH | 44.11 | 17715132 | |
| 307 | Ubiquitination | RQKTDVLKVYEILPT CCCCCHHHHEECCCC | 42.49 | - | |
| 309 | Phosphorylation | KTDVLKVYEILPTFD CCCHHHHEECCCCCC | 8.82 | - | |
| 343 | Ubiquitination | EENISEVKSYKCLKV HCCHHHHHHHHHHHH | 43.97 | - | |
| 347 | S-nitrosylation | SEVKSYKCLKVLENI HHHHHHHHHHHHHHH | 3.18 | - | |
| 347 | S-nitrosocysteine | SEVKSYKCLKVLENI HHHHHHHHHHHHHHH | 3.18 | - | |
| 355 | Ubiquitination | LKVLENIKSSGQGID HHHHHHHHHCCCCCC | 50.58 | - | |
| 381 (in isoform 1) | Ubiquitination | - | 45.02 | 21906983 | |
| 381 (in isoform 2) | Ubiquitination | - | 45.02 | 21906983 | |
| 381 | Ubiquitination | KMDVVDGKTPMSAEM EEEECCCCCCCCHHH | 45.02 | 21906983 | |
| 385 | Phosphorylation | VDGKTPMSAEMREEQ CCCCCCCCHHHHHHH | 23.45 | - | |
| 406 | Phosphorylation | LQGMNIDSETKANNG HCCCCCCCCCCCCCC | 43.28 | 25627689 | |
| 408 | Phosphorylation | GMNIDSETKANNGEK CCCCCCCCCCCCCCC | 39.13 | 21815630 | |
| 409 | Ubiquitination | MNIDSETKANNGEKN CCCCCCCCCCCCCCH | 45.10 | 2190698 | |
| 409 (in isoform 1) | Ubiquitination | - | 45.10 | 21906983 | |
| 424 | Phosphorylation | ARQRLLDSSC----- HHHHHHHCCC----- | 33.31 | 28450419 | |
| 425 | Phosphorylation | RQRLLDSSC------ HHHHHHCCC------ | 24.42 | 28450419 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PANX1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PANX1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| GNAS3_HUMAN | GNAS | physical | 16293724 | |
| GNAS2_HUMAN | GNAS | physical | 16293724 | |
| ALEX_HUMAN | GNAS | physical | 16293724 | |
| GNAS1_HUMAN | GNAS | physical | 16293724 |
| Kegg Disease | |
|---|---|
| There are no disease associations of PTM sites. | |
| OMIM Disease | |
| There are no disease associations of PTM sites. | |
| Kegg Drug | |
| There are no disease associations of PTM sites. | |
| DrugBank | |
| DB01032 | Probenecid |
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Pannexin1 channels contain a glycosylation site that targets thehexamer to the plasma membrane."; Boassa D., Ambrosi C., Qiu F., Dahl G., Gaietta G., Sosinsky G.; J. Biol. Chem. 282:31733-31743(2007). Cited for: GLYCOSYLATION AT ASN-255, HOMOHEXAMERIZATION, SUBCELLULAR LOCATION,AND MUTAGENESIS OF ASN-255. | |